NASDAQ : XLO
Xilio Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 8.03 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 52.84M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Xilio Therapeutics, Inc. (XLO) reported revenue of 64.09M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 64.09M | 43.77M | 6.34M | |||
| Gross Profit | 53.30M | 43.77M | 6.34M | |||
| Selling, General & Admin | 28.63M | 29.71M | 24.78M | 27.00M | 29.95M | 23.86M |
| Research & Development | 56.04M | 56.04M | 41.21M | 52.14M | 59.20M | 51.19M |
| Operating Expenses | 84.67M | 85.75M | 65.99M | 79.13M | 89.15M | 75.04M |
| Operating Income | -31.37M | -41.98M | -59.65M | -79.13M | -89.15M | -75.04M |
| Interest Expense | -700.00K | -800.00K | -600.00K | |||
| Other Non Operating Income (Expenses) | 9.54M | 6.95M | 2.34M | 3.43M | 1.73M | -156.00K |
| EBT Excluding Unusual Items | -21.83M | -35.04M | -57.30M | -76.40M | -88.22M | -75.80M |
| Merger & Restructuring Charges | -937.00K | |||||
| Pretax Income | -21.83M | -35.04M | -58.24M | -76.40M | -88.22M | -75.80M |
| Net Income | -21.83M | -35.04M | -58.24M | -76.40M | -88.22M | -75.80M |
| Net Income to Common | -21.83M | -35.04M | -58.24M | -76.40M | -88.22M | -75.80M |
| Shares Outstanding (Basic) | 6.58M | 4.53M | 3.82M | 1.96M | 1.96M | 400.45K |
| Shares Outstanding (Diluted) | 6.58M | 4.53M | 3.82M | 1.96M | 1.96M | 400.45K |
| EPS (Basic) | -3.32 | -7.73 | -15.24 | -38.90 | -45.09 | -189.29 |
| EPS (Diluted) | -3.32 | -7.73 | -15.24 | -38.90 | -45.09 | -189.29 |
| Free Cash Flow | -61.27M | -5.51M | -18.41M | -69.11M | -77.59M | -81.85M |
| Free Cash Flow Per Share | -9.31 | -1.22 | -4.82 | -35.19 | -39.66 | -204.40 |
| Gross Margin | 83.16% | 100.00% | 100.00% | |||
| Operating Margin | -48.94% | -95.92% | -940.18% | |||
| Profit Margin | -34.06% | -80.05% | -918.05% | |||
| Free Cash Flow Margin | -95.59% | -12.59% | -290.26% | |||
| EBITDA | -30.03M | -40.44M | -58.00M | -77.23M | -87.30M | -73.55M |
| EBITDA Margin | -46.85% | -92.40% | ||||
| D&A For EBITDA | 1.34M | 1.54M | 1.64M | 1.90M | 1.85M | 1.50M |
| EBIT | -31.37M | -41.98M | -59.65M | -79.13M | -89.15M | -75.04M |
| EBIT Margin | -48.94% | -95.92% | ||||
| Revenue as Reported | 64.09M | 43.77M | 6.34M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 136.04M | 137.53M | 55.29M | 44.70M | 120.39M | 198.05M |
| Cash & Short-Term Investments | 136.04M | 137.53M | 55.29M | 44.70M | 120.39M | 198.05M |
| Receivables | 6.00M | 5.00M | ||||
| Prepaid Expenses | 3.43M | 2.50M | 4.94M | 3.42M | 4.11M | 4.46M |
| Total Current Assets | 145.47M | 145.03M | 60.23M | 48.13M | 124.50M | 202.52M |
| Property, Plant & Equipment | 6.97M | 7.85M | 9.06M | 11.20M | 13.06M | 13.90M |
| Other Long-Term Assets | 1.82M | 1.81M | 1.78M | 1.60M | 1.61M | 1.64M |
| Total Assets | 154.25M | 154.69M | 71.08M | 60.93M | 139.16M | 218.06M |
| Accounts Payable | 2.31M | 3.17M | 2.57M | 1.05M | 3.12M | 3.14M |
| Accrued Expenses | 7.85M | 11.74M | 9.98M | 10.50M | 10.33M | 8.75M |
| Current Portion of Long-Term Debt | 3.31M | 6.67M | ||||
| Current Portion of Leases | 1.43M | 1.34M | 1.19M | 1.09M | 1.00M | 883.00K |
| Current Unearned Revenue | 22.60M | 40.02M | 13.52M | |||
| Total Current Liabilities | 34.20M | 56.27M | 27.26M | 15.96M | 21.12M | 12.78M |
| Long-Term Debt | 3.17M | 9.63M | ||||
| Long-Term Leases | 4.88M | 5.61M | 6.95M | 8.14M | 9.23M | 10.22M |
| Long-Term Unearned Revenue | 12.71M | 20.64M | 19.26M | |||
| Other Long-Term Liabilities | 30.20M | 36.89M | ||||
| Total Liabilities | 81.99M | 119.41M | 53.48M | 24.10M | 33.52M | 32.63M |
| Common Stock | 1.00K | 3.00K | 3.00K | 3.00K | ||
| Additional Paid-In Capital | 506.95M | 454.06M | 401.35M | 362.34M | 354.75M | 346.31M |
| Retained Earnings | -434.69M | -418.79M | -383.75M | -325.51M | -249.11M | -160.89M |
| Total Common Equity | 72.26M | 35.27M | 17.60M | 36.83M | 105.65M | 185.43M |
| Shareholders' Equity | 72.26M | 35.27M | 17.60M | 36.83M | 105.65M | 185.43M |
| Total Liabilities & Equity | 154.25M | 154.69M | 71.08M | 60.93M | 139.16M | 218.06M |
| Total Debt | 6.30M | 6.95M | 8.14M | 12.55M | 20.07M | 20.74M |
| Net Cash (Debt) | 129.74M | 130.58M | 47.15M | 32.15M | 100.32M | 177.32M |
| Net Cash Per Share | 19.72 | 28.82 | 12.34 | 16.37 | 51.27 | 442.79 |
| Filing Date Shares Outstanding | 6.58M | 5.78M | 3.70M | 2.46M | 1.96M | 1.95M |
| Total Common Shares Outstanding | 6.58M | 4.53M | 3.27M | 1.97M | 1.96M | 1.95M |
| Working Capital | 111.27M | 88.75M | 32.97M | 32.17M | 103.38M | 189.74M |
| Book Value Per Share | 10.98 | 7.79 | 5.38 | 18.68 | 53.93 | 94.89 |
| Tangible Book Value | 72.26M | 35.27M | 17.60M | 36.83M | 105.65M | 185.43M |
| Tangible Book Value Per Share | 10.98 | 7.79 | 5.38 | 18.68 | 53.93 | 94.89 |
| Machinery | 7.64M | 7.06M | 6.78M | 6.68M | 6.45M | 4.67M |
| Construction In Progress | 459.00K | 98.00K | 539.00K | |||
| Leasehold Improvements | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.83M | -35.04M | -58.24M | -76.40M | -88.22M | -75.80M |
| Depreciation & Amortization | 1.34M | 1.54M | 1.64M | 1.90M | 1.85M | 1.50M |
| Loss (Gain) From Sale of Assets | 3.00K | 3.00K | 1.00K | 19.00K | ||
| Stock-Based Compensation | 7.86M | 6.94M | 6.43M | 7.38M | 8.42M | 4.96M |
| Other Operating Activities | -5.25M | -3.56M | 157.00K | 223.00K | 376.00K | |
| Change in Accounts Receivable | -6.00M | -5.00M | ||||
| Change in Accounts Payable | -1.79M | 152.00K | 1.53M | -2.06M | 485.00K | -2.82M |
| Change in Unearned Revenue | -35.59M | 27.88M | 32.78M | |||
| Change in Other Net Operating Assets | 667.00K | 2.10M | -2.52M | 405.00K | 1.52M | -8.98M |
| Operating Cash Flow | -60.60M | -4.99M | -18.38M | -68.62M | -75.72M | -80.75M |
| Capital Expenditures | -670.00K | -518.00K | -36.00K | -486.00K | -1.87M | -1.10M |
| Investing Cash Flow | -670.00K | -518.00K | -36.00K | -486.00K | -1.87M | -1.10M |
| Long-Term Debt Issued | 975.00K | |||||
| Long-Term Debt Repaid | -3.38M | -6.75M | -85.00K | -1.08M | ||
| Net Debt Issued (Repaid) | -3.38M | -6.75M | -85.00K | -110.00K | ||
| Issuance of Common Stock | 77.33M | 87.78M | 32.58M | 202.00K | 16.00K | 116.64M |
| Other Financing Activities | -1.55M | -750.00K | ||||
| Financing Cash Flow | 75.78M | 87.78M | 29.20M | -6.55M | -69.00K | 260.67M |
| Net Cash Flow | 14.51M | 82.27M | 10.78M | -75.66M | -77.66M | 178.82M |
| Free Cash Flow | -61.27M | -5.51M | -18.41M | -69.11M | -77.59M | -81.85M |
| Free Cash Flow Margin | -95.59% | -12.59% | -290.26% | |||
| Free Cash Flow Per Share | -9.31 | -1.22 | -4.82 | -35.19 | -39.66 | -204.40 |
| Levered Free Cash Flow | -37.56M | 8.03M | -16.23M | -42.32M | -45.90M | -52.31M |
| Unlevered Free Cash Flow | -37.56M | 8.03M | -16.23M | -41.88M | -45.40M | -51.94M |
| Cash Interest Paid | 62.00K | 573.00K | 555.00K | 492.00K | ||
| Change in Working Capital | -42.71M | 25.12M | 31.78M | -1.66M | 2.00M | -11.80M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 52.58M | 33.61M | 41.98M | 15.14M | 73.73M | 437.33M |
| Enterprise Value | -77.16M | -62.89M | -10.86M | -30.18M | -45.17M | 581.20M |
| Last Close Price | 8.03 | 8.96 | 13.37 | 7.70 | 37.66 | 224.00 |
| PS Ratio | 0.80 | 0.77 | 6.62 | |||
| PB Ratio | 0.73 | 0.95 | 2.38 | 0.41 | 0.70 | 2.36 |
| P/TBV Ratio | 0.71 | 0.95 | 2.38 | 0.41 | 0.70 | 2.36 |
| Debt / Equity Ratio | 0.09 | 0.20 | 0.46 | 0.34 | 0.19 | 0.11 |
| Net Debt / Equity Ratio | -1.79 | -3.70 | -2.68 | -0.87 | -0.95 | -0.96 |
| Net Debt / EBITDA Ratio | 4.32 | 3.23 | 0.81 | 0.42 | 1.15 | 2.41 |
| Net Debt / FCF Ratio | 2.12 | 23.70 | 2.56 | 0.47 | 1.29 | 2.17 |
| Asset Turnover | 0.45 | 0.39 | 0.10 | |||
| Quick Ratio | 4.15 | 2.53 | 2.03 | 2.80 | 5.70 | 15.50 |
| Current Ratio | 4.25 | 2.58 | 2.21 | 3.02 | 5.89 | 15.85 |
| Return on Equity (ROE) | -55.03% | -132.53% | -214.02% | -107.25% | -60.62% | -84.16% |
| Return on Assets (ROA) | -13.61% | -23.24% | -56.48% | -49.44% | -31.20% | -36.88% |
| Return on Capital Employed (ROCE) | -26.10% | -42.70% | -136.10% | -176.00% | -75.50% | -36.60% |
| Earnings Yield | -41.52% | -104.24% | -138.74% | -504.62% | -119.66% | -17.33% |
| FCF Yield | -119.07% | -16.39% | -43.86% | -456.42% | -105.24% | -18.72% |
| Buyback Yield / Dilution | -77.75% | -18.53% | -94.61% | -0.38% | -388.59% | -970.35% |